Table 4: SIV in relation to MFN entry price and preferential entry price of MED’s
exports of oranges to the EU, December 1, 1995-May 31, 2005
Number |
SIV > MFN EP (in % of |
SIV < applied EP* |
SIV as % |
SIV as % | ||
number of |
in % of | |||||
Israel |
961 |
99.9% |
0 |
0% |
158.3% |
212.4% |
Tunisia |
854 |
97.2% |
24 |
2.8% |
141.5% |
185.8% |
Turkey |
1,132 |
92% |
90 |
8.0% |
144.5% |
193.8% |
Morocco |
1,133 |
93% |
0 |
0.0% |
127.6% |
171.1% |
Egypt |
746 |
79.1% |
31 |
4.2% |
124.1% |
166.5% |
Cyprus |
613 |
98.7% |
2 |
0.3% |
144.4% |
193.7% |
Total |
5439 |
93.3% |
147 |
2.7% |
140.1% |
187.9% |
*for Morocco and Israel: applied EP=pref. EP; for Turkey and Tunisia: applied EP=MFN EP; for Egypt: applied
EP= MFN EP before Dec. 96 and pref. EP afterwards; for Cyprus: applied EP=MFN EP before Dec. 97; pref. EP
afterwards
Sources: European Commission (2005a, 2005b), own calculations
Figure 4: SIV and MFN entry price of MED’s exports of table grapes to the EU,
December 1, 1995-May 31, 2005

-MFN EP
SIV
Sources: European Commission (2005a, 2005b).
10
More intriguing information
1. The name is absent2. The Shepherd Sinfonia
3. Better policy analysis with better data. Constructing a Social Accounting Matrix from the European System of National Accounts.
4. Cardiac Arrhythmia and Geomagnetic Activity
5. Staying on the Dole
6. Structural Breakpoints in Volatility in International Markets
7. Short- and long-term experience in pulmonary vein segmental ostial ablation for paroxysmal atrial fibrillation*
8. Anti Microbial Resistance Profile of E. coli isolates From Tropical Free Range Chickens
9. Subduing High Inflation in Romania. How to Better Monetary and Exchange Rate Mechanisms?
10. The name is absent